NCT07294937 Study Protocol: 10-Year Follow-Up of Patients Screened for Cardiovascular Risk by the "All With Heart" Association - Development of a Morocco-Specific Risk Score
| NCT ID | NCT07294937 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Moroccan Society of Cardiology |
| Condition | Cardiovascular Diseases (CVD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2025-10-01 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, and their prevalence is steadily increasing in Morocco. Between 2010 and 2012, the "All with heart" Association conducted a large-scale cardiovascular screening campaign in the Greater Casablanca region, involving more than 10,000 adults aged over 40 years. This 10-year follow-up study aims to evaluate long-term cardiovascular outcomes and to develop a Morocco-specific cardiovascular risk score. Follow-up data will be collected through phone calls, WhatsApp, or SMS with participants or their families to document cardiovascular deaths, myocardial infarctions, and strokes. Statistical analyses, including survival analysis and multivariate logistic regression, will be used to identify significant risk factors and to construct a predictive risk model tailored to the Moroccan population. The study received a favorable opinion from the Rabat Ethics Committee. Written informed consent will be obtained from all participants or their families prior to data collection. The findings are expected to enhance understanding of cardiovascular risk evolution in Morocco and to provide a validated, population-specific risk score to support prevention and patient management strategies.
Eligibility Criteria
Inclusion Criteria: * Adults aged 40 years or older at the time of the initial screening (2010-2012). * Individuals who participated in the cardiovascular risk screening campaign conducted by the "All with heart" Association between 2010 and 2012 in the Greater Casablanca region. * Moroccan nationality. * Participants or family members who provide written informed consent for participation in the 10-year follow-up study. Exclusion Criteria: * Individuals who refuse to participate in the follow-up study. * Participants who have moved and cannot be reached by phone, WhatsApp, or SMS. * Participants who died from non-cardiovascular causes. * Non-Moroccan participants.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07294937 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Cardiovascular Diseases (CVD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07294937 currently recruiting?
Yes, NCT07294937 is actively recruiting participants. Contact the research team at mouine2@yahoo.fr for enrollment information.
Where is the NCT07294937 trial being conducted?
This trial is being conducted at Casablanca, Morocco, Rabat, Morocco.
Who is sponsoring the NCT07294937 clinical trial?
NCT07294937 is sponsored by Moroccan Society of Cardiology. The trial plans to enroll 10,000 participants.